#anthropic拒绝延期ipo,本周路演估值几何?

Anthropic is being tough, but realistic.

They said the IPO wouldn’t be delayed, and it won’t be. They’ve slashed the valuation from $2 trillion to $1.4 trillion without batting an eye.

I watched the roadshow video. The numbers the CFO threw out weren’t bad: third-quarter revenue was nearly $17 billion, up 12-fold year over year; gross margin for the first three quarters was 85%; engineers generated 45 times as much code per person as in 2024, while revenue per employee rose from $1.4 million to over $6.6 million.

Dario went even further, taking the vision to the absolute limit: making cancer and Alzheimer’s a thing of the past in less than a decade. He doesn’t bother debating whether “AI is a bubble.” He’s betting everything on ending human disease and reinventing the science of the physical world. And he put it beautifully: “If we get it right, we can usher in an age of miracles.”

But capital markets don’t buy sentiment.

As soon as the prospectus was updated, the fully diluted market cap was set at $1.4 trillion, down 30% from the $2 trillion that had been widely discussed. The top end of the offering price is $78 per share, with a base offering of about $64.4 billion. Add the $26 billion in private placements from Google, Nvidia, and Microsoft, and the total could reach $90.4 billion. With the overallotment option, it could approach the $100 billion mark. It would still be one of the largest IPOs in Wall Street history.

So why accept the cut?

Because investors are bargaining. Compute commitments are close to $900 billion, third-quarter growth slowed from 144% to 47%, and the company also offered a price discount of about $600 million. Slower growth, bigger bills, and a lower valuation—all three together, and of course buyers want a discount. Index funds and large asset managers—the “forced buyers”—will come in, but that doesn’t mean they’re genuinely bullish; it’s rule-driven, passive allocation.

Put simply, capital markets talk returns, while Dario talks miracles.